ReviewAnnals of hematology2008

The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.

Torsten Haferlach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.